Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 243 - Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
Patents for C07D 243 - Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms (5,961)
12/2005
12/07/2005CN1705647A Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
12/01/2005WO2005113542A2 N-cyclic sulfonamido inhibitors of gamma secretase
12/01/2005WO2005113517A1 Phosphodiesterase-inhibiting compounds of the 2,3-benzodiazepine type
12/01/2005WO2005077899A3 Amino-substituted tricyclic derivatives and methods of use
12/01/2005US20050267100 For therapy of obesity
12/01/2005CA2567343A1 N-cyclic sulfonamido inhibitors of gamma secretase
11/2005
11/30/2005EP1140786B1 Reductive alkylation of secondary amines with hydrosilane
11/30/2005CN1703401A Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
11/29/2005US6969710 Compounds
11/24/2005WO2005111001A1 Novel fused heterocycles and uses thereof
11/24/2005WO2004089313A3 Novel olanzapine forms and related methods of treatment
11/24/2005US20050261318 Protein kinase inhibitors
11/24/2005US20050261274 1-[3-Methyl-1-(5-methyl-6-oxo-benzo[b]-1,4-diazepin-7-ylcarbamoyl)-butyl]-cyclohexanecarboxylic acid amide; inhibit processing of amyloid precursor protein (production of A beta -peptide); neurological disorders related to beta -amyloid production: Alzheimer's disease, Down's Syndrome
11/24/2005US20050261176 Compositions and methods relating to novel compounds and targets thereof
11/23/2005EP1597260A1 Triazole compounds useful in therapy
11/16/2005EP1594879A1 Process and intermediates for the preparation of olanzapine
11/16/2005EP1317442B1 Quinolinone derivatives as tyrosine kinase inhibitors
11/16/2005EP0979227B1 4,1-benzoxazepines, their analogues, and their use as somatostatin agonists
11/13/2005CA2507567A1 Use of compositions comprising farnesyl dibenzodiazepinones for treating neoplastic cells and conditions
11/10/2005DE102004019492A1 Ausgewählte CGRP-Antagonisten, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel Selected CGRP antagonists, processes for their preparation and their use as medicaments
11/09/2005EP1592684A1 Malonamide derivatives as gamma-secretase inhibitors
11/09/2005EP1592673A2 Novel substituted 2,3-benzodiazepine derivatives
11/09/2005EP1095016B1 Sulfur substituted sulfonylaminocarboxylic acid n-arylamides, their preparation, their use and pharmaceutical preparations comprising them
11/09/2005CN1694874A Benzodiazepine derivatives and pharmaceutical compositions containing them
11/09/2005CN1226292C Diazesuberane derivant or its salt
11/08/2005US6962913 Benzo-1,4-diazepin-2-ones as inhibitors of Aβ protein production
11/08/2005US6962912 Substituted pyrazolo[4,3-e]diazepines, pharmaceutical compositions containing them, use as medicinal products and processes for preparing them
11/03/2005WO2005103041A2 Treatment of cns disorders using cns target modulators
11/03/2005WO2005103037A2 Selected cgrp antagonists, methods for the production thereof, and use thereof as medicaments
11/03/2005US20050245551 Amide derivatives
11/03/2005US20050245505 Novel heterocyclic compounds, method for preparing same and use thereof as medicines, in particular as antibacterial agents
11/03/2005US20050245501 Succinoylamino lactams as inhibitors of A-beta protein production
11/03/2005CA2565219A1 Selected cgrp antagonists, methods for the production thereof, and use thereof as medicaments
11/03/2005CA2563826A1 Treatment of cns disorders using cns target modulators
11/02/2005EP1590342A1 Diazepanes derivatives useful as lfa inhibitors
11/02/2005CN1692109A Novel compounds as NS3-serine protease inhibitors of hepatitis c virus
11/01/2005US6960578 Glutamate receptor antagonists
11/01/2005US6960576 Hydroxyalkanoylaminolactams and related structures as inhibitors of Aβ protein production
10/2005
10/27/2005US20050239054 Drug screening compounds having esterified phosphonate or carboxyl groups with novel enzyme GS-7340 Ester Hydrolase and identifying the compound as a suitable prodrug by the formation of a phosphonic acid or carboxylic acid; candidate compounds
10/26/2005EP1587473A2 Thiosemicarbazones as anti-virals and immunopotentiators
10/26/2005EP1289965B1 Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
10/26/2005EP0762880B1 Retroviral protease inhibitor combinations
10/25/2005US6958329 1-[3-Methyl-1-(5-methyl-6-oxo-6,7-dihydro-5H-dibenzo[b,d]-azepin-7-ylcarbamoyl)-butyl]-cyclohexanecarboxylic acid amide; inhibit processing of amyloid precursor protein (production of A beta -peptide); neurological disorders related to beta -amyloid production: Alzheimer's disease, Down's Syndrome
10/20/2005US20050234048 substituted 4,5-dihydro-1H-benzo[b][1,4]-diazepin-2-one; amidation of a substituted monoprotected 1,2-diaminobenzene with an ester, deprotecting, cyclization; chronic neurological disorders, psychosis, schizophrenia, Alzheimer's disease
10/20/2005US20050234039 Substituted lactams as inhibitors of Abeta protein production
10/19/2005EP1585814A1 Farnesyl dibenzodiazepinones, processes for their production and their use as pharmaceuticals
10/19/2005EP1585511A2 Asthma and allergic inflammation modulators
10/19/2005EP1102752B1 Succinoylamino lactams as inhibitors of a beta protein production
10/19/2005CN1684965A Novel 1, 4-diazabicycloalkane derivatives, their preparation and use
10/13/2005WO2005054211A8 A method of purification of lorazepam
10/13/2005US20050227967 Treatment of T-helper cell type 2-mediated immune diseases by retinoid antagonists
10/12/2005EP1583745A1 1-propanol and 1-propylamine derivatives and their use as glucocorticoid ligands
10/12/2005CN1680338A Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
10/11/2005US6953857 Oxybenzamide derivatives useful for inhibiting factor Xa or viia
10/11/2005US6953801 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
10/11/2005US6953788 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase
10/06/2005WO2005091697A2 Thiourea compositions and uses thereof
10/05/2005EP1581476A2 Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors
10/05/2005CN1221538C Calcium salts of 1, 5-benzodiazepine derivatives, process for producing salts and drugs containing same
10/04/2005US6951872 Monocyclic or bicyclic carbocycles and heterocycles as factor Xa inhibitors
10/04/2005CA2245539C Condensed 2,3-benzodiazepine derivatives and their use as ampa-receptor inhibitors
09/2005
09/29/2005WO2005090322A1 Derivatives of alkylpiperazine- and alkylhomopiperazine- carboxylates, preparation method thereof and use of same as faah enzyme inhibitors
09/29/2005WO2005090319A1 Process for preparing benzodiazepines
09/29/2005WO2005089770A1 Benzodiazepines for treating or preventing or preventing rsv infection
09/29/2005US20050215783 Thiourea compositions and uses thereof
09/29/2005CA2557929A1 Benzodiazepines for treating or preventing or preventing rsv infection
09/29/2005CA2554855A1 Derivatives of alkylpiperazine- and alkylhomopiperazine- carboxylates, preparation method thereof and use of same as faah enzyme inhibitors
09/28/2005EP1578198A1 Pesticidal dibenzo(hetero)azepine derivatives
09/27/2005US6949534 An amide compound containing a very late antigen of activation-4 (VLA-4) specifity determinanat which doesn't impart significant IIb/IIIa activity; antiinflammatory agent and useful for treating autoimmune disorders
09/27/2005CA2192731C Monohydrates of aminobenzenesulfonic acid derivatives and method for preparing thereof
09/22/2005WO2005087236A1 Novel m3 muscarinic acetylcholine receptor antagonists
09/22/2005WO2005016876A3 Cyclic amine bace-1 inhibitors having a benzamide substituent
09/22/2005WO2004060376A8 The r-isomer of beta amino acid compounds as integrin receptor antagonists derivatives
09/22/2005US20050209456 Vascular endothelial growth factor; tyrosine kinase inhibitor; angiogenesis inhibitor; anticancer agents
09/22/2005US20050209197 Cellular accumulation of phosphonate analogs of HIV protease inhibitor compounds
09/21/2005EP1575486A2 Method and compositions for identifying anti-hiv therapeutic compounds
09/21/2005CN1219517C Complex of ras-farnesyltransferase inhibitor and sulfobutylether-7-beta cyclodextrin or 2-hydroxypropyl-beta-cyclodextrin and method
09/20/2005CA2285119C Retroviral protease inhibiting compounds
09/15/2005WO2005084668A1 Medicine for prevention and/or treatment of ischemic circulatory disease
09/15/2005US20050203296 Piperazine substituted aryl benzodiazepines and their use as dopamine receptor antagonists for the treatment of psychotic disorders
09/15/2005CA2557262A1 Medicament for preventing and/or treating ischemic cardiovascular disease
09/14/2005EP1572678A2 Substituted n-phenyl sulfonamide bradykinin antagonists
09/14/2005EP1572210A1 The r-isomer of beta amino acid compounds as integrin receptor antagonists derivatives
09/09/2005WO2005058884A3 Cyclopropane compounds and pharmaceutical use thereof
09/08/2005US20050197320 Phosphonate and sulfide substituted imidazole compounds; antihuman immunodeficiency viral agents
09/07/2005CN1665801A Anti tubercular drug: compositions and methods
09/07/2005CN1217938C Bis-arylsulfones
09/01/2005WO2005080976A1 Method of in vivo screening of therapeutic agent for memory/learning dysfunction by schizophrenia
08/2005
08/31/2005EP1567511A1 Substituted piperazines, (1,4) diaszepines, and 2,5-diazabicyclo (2.2.1) heptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists
08/31/2005CN1662516A N, N-disubstituted diazocycloalkanes
08/31/2005CN1660822A Oxime functionalized new type compound of kinitrogen cyclic amine and synthetic method
08/25/2005WO2005077899A2 Amino-substituted tricyclic derivatives and methods of use
08/25/2005US20050187272 Enzyme inhibitor on NO-synthase enzymes; treating STROKE, NEURODEGENERATIVE DISEASES, preventing ISCHEMIC OR HEMORRAGIC CARDIAC OR CEREBRAL INFARCTIONS; inhibiting lipidic peroxidation
08/25/2005CA2555884A1 Amino-substituted tricyclic derivatives and methods of use
08/24/2005CN1659156A Novel guanidinobenzamides
08/18/2005WO2004069197A3 Novel substituted 2,3-benzodiazepine derivatives
08/18/2005US20050182068 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
08/18/2005US20050182047 Treatment of demyelinating disorders
08/17/2005EP1377558B1 [1,4]-diazepane-1-carboxylic acid derivatives, process for their preparation and their use as tachykinin antagonists
08/17/2005CN1656109A Non nucleoside reverse transcriptase inhibitors
1 ... 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 ... 60